Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription 01.04.2024 1 BMC Cancer 1 Eur J Obstet Gynecol Reprod Biol 4 Gynecol Oncol 1 Int J Cancer 2 J Clin Oncol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. ALWAFAI Z, Beck MH, Fazeli S, Gurtler K, et al
   Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO.
   BMC Cancer. 2024;24:380.
   PubMed         Abstract available
   
   

   
   Eur J Obstet Gynecol Reprod Biol

2. NATARAJAN P, Martha Schofield A, Elena Vinturache A, Ruthven S, et al
   A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet(R) device.
   Eur J Obstet Gynecol Reprod Biol. 2024;296:311-315.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

3. CHEN W, Xie J, Gao C, Zhang C, et al
   Hypertension associated with niraparib in cancer patients: A pharmacovigilance analysis based on the FAERS database and meta-analysis of randomized controlled trials.
   Gynecol Oncol. 2024;182:108-114.
   PubMed         Abstract available
   
   
4. CASANOVA J, Duarte GS, da Costa AG, Catarino A, et al
   Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis.
   Gynecol Oncol. 2024;182:99-107.
   PubMed         Abstract available
   
   
5. CRISTEA MC, Stewart D, Synold T, Ruel N, et al
   A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRalpha-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer.
   Gynecol Oncol. 2024;182:124-131.
   PubMed         Abstract available
   
   
6. FIFE AJ, Najor AJ, Aspir TB, Haines KE, et al
   Reduced healthcare access contributes to delay of care in endometrial cancer.
   Gynecol Oncol. 2024;182:115-120.
   PubMed         Abstract available
   
   

   
   Int J Cancer

7. DUUS AH, Hannibal CG, Baandrup L, Zheng G, et al
   Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study.
   Int J Cancer. 2024 Mar 26. doi: 10.1002/ijc.34936.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

8. MUTLU SUTCUOGLU B, Sutcuoglu O
   Interpretation of the EORTC-55954 Trial: Does the Response to Neoadjuvant Chemotherapy Have an Effect on Disease Outcome?
   J Clin Oncol. 2024;42:1204-1205.
   PubMed        
   
   
9. HAN CY, Lu KH, Corrigan G, Perez A, et al
   Normal Risk Ovarian Screening Study: 21-Year Update.
   J Clin Oncol. 2024;42:1102-1109.
   PubMed         Abstract available
   
   

   
   PLoS One

10. KANG J, Na K, Kang H, Cho U, et al
    Prediction of homologous recombination deficiency from Oncomine Comprehensive Assay Plus correlating with SOPHiA DDM HRD Solution.
    PLoS One. 2024;19:e0298128.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.